Arkolith/Insider Trading/TRAW

TRAW Insider Trading

TRAW · full profile →Last filing Mar 8, 2026
Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

64 shown
DateInsiderRoleActionSharesPriceValue
Mar 8, 2026Stover Jack EDirectorGrant(A)33K—$0
Mar 8, 2026Cautreels WernerDirectorGrant(A)31K—$0
Mar 8, 2026Leaman John HaroldDirectorGrant(A)33K—$0
Mar 8, 2026Dukes Iain D.Chief Executive Officer, DirectorGrant(A)231K—$0
Mar 8, 2026Shoemaker Mary TeresaDirectorGrant(A)33K—$0
Mar 8, 2026Clarke TraffordDirectorGrant(A)33K—$0
Mar 8, 2026Savchuk NikolayChief Operating Officer, DirectorGrant(A)97K—$0
Mar 8, 2026Pauza Charles DavidChief Science Officer VirologyGrant(A)118K—$0
Mar 8, 2026Redfield RobertChief Medical OfficerGrant(A)109K—$0
Dec 12, 2025Stover Jack EDirectorGrant(A)6K—$0
Dec 12, 2025Stover Jack EDirectorGrant(A)25K—$0
Dec 12, 2025Cautreels WernerDirectorGrant(A)5K—$0
Dec 12, 2025Cautreels WernerDirectorGrant(A)19K—$0
Dec 12, 2025Leaman John HaroldDirectorGrant(A)4K—$0
Dec 12, 2025Leaman John HaroldDirectorGrant(A)16K—$0
Dec 12, 2025Dukes Iain D.Chief Executive Officer, DirectorGrant(A)37K—$0
Dec 12, 2025Dukes Iain D.Chief Executive Officer, DirectorGrant(A)148K—$0
Dec 12, 2025Shoemaker Mary TeresaDirectorGrant(A)6K—$0
Dec 12, 2025Shoemaker Mary TeresaDirectorGrant(A)25K—$0
Dec 12, 2025Clarke TraffordDirectorGrant(A)6K—$0
Dec 12, 2025Clarke TraffordDirectorGrant(A)25K—$0
Dec 12, 2025Savchuk NikolayChief Operating Officer, DirectorGrant(A)16K—$0
Dec 12, 2025Savchuk NikolayChief Operating Officer, DirectorGrant(A)66K—$0
Dec 12, 2025Pauza Charles DavidChief Science Officer VirologyGrant(A)18K—$0
Dec 12, 2025Pauza Charles DavidChief Science Officer VirologyGrant(A)74K—$0
Dec 12, 2025Redfield RobertChief Medical OfficerGrant(A)16K—$0
Dec 12, 2025Redfield RobertChief Medical OfficerGrant(A)66K—$0
Nov 21, 2025Leaman John HaroldDirectorGrant(A)13K—$0
Oct 12, 2025Stover Jack EDirectorGrant(A)12K—$0
Oct 12, 2025Cautreels WernerDirectorGrant(A)12K—$0
Oct 12, 2025Dukes Iain D.Chief Executive Officer, DirectorGrant(A)65K—$0
Oct 12, 2025Shoemaker Mary TeresaDirectorGrant(A)12K—$0
Oct 12, 2025Clarke TraffordDirectorGrant(A)12K—$0
Oct 12, 2025Savchuk NikolayChief Operating Officer, DirectorGrant(A)22K—$0
Oct 12, 2025Pauza Charles DavidChief Science Officer VirologyGrant(A)32K—$0
Oct 12, 2025Redfield RobertChief Medical OfficerGrant(A)32K—$0
Oct 1, 2025Leaman John HaroldDirectorGrant(A)16K—$0
Jun 19, 2025Cautreels WernerDirectorGrant(A)23K—$0
Jun 19, 2025Shoemaker Mary TeresaDirectorGrant(A)23K—$0
Jun 19, 2025Stover Jack EDirectorGrant(A)23K—$0
Jun 19, 2025Clarke TraffordDirectorGrant(A)23K—$0
Apr 2, 2025Savchuk NikolayChief Operating Officer, 10% OwnerOther(J)606K——
Apr 2, 2025Savchuk NikolayChief Operating Officer, 10% OwnerOther(J)2K—$0
Feb 18, 2025Cautreels WernerChief Executive Officer, DirectorOption exercise(M)96K$0.01$963
Feb 18, 2025Cautreels WernerChief Executive Officer, DirectorOption exercise(M)96K—$0
Dec 29, 2024Savchuk NikolayChief Operating Officer, Director, 10% OwnerBuy(P)96K——
Dec 29, 2024Savchuk NikolayChief Operating Officer, Director, 10% OwnerBuy(P)96K——
Dec 29, 2024Tpav, LLC10% OwnerBuy(P)96K——
Dec 29, 2024Tpav, LLC10% OwnerBuy(P)96K——
Dec 29, 2024Cautreels WernerChief Executive Officer, DirectorBuy(P)96K——
Dec 29, 2024Cautreels WernerChief Executive Officer, DirectorBuy(P)96K——
Dec 29, 2024OrbiMed Capital GP VIII LLC10% OwnerBuy(P)96K——
Dec 29, 2024OrbiMed Capital GP VIII LLC10% OwnerBuy(P)96K——
Sep 16, 2024Greenwood LubaDirectorGrant(A)164K—$0
Jun 18, 2024Guerin Mark PatrickCFOTax withholding(F)2K$0.47$1K
Jun 18, 2024Guerin Mark PatrickCFOOption exercise(M)6K—$0
Jun 10, 2024Guerin Mark PatrickCFOOption exercise(M)6K——
Apr 1, 2024Savchuk NikolayChief Operating Officer, DirectorGrant(A)68K——
Apr 1, 2024Dukes Iain D.Executive Chairman, DirectorGrant(A)68K——
Apr 1, 2024Cautreels WernerChief Executive Officer, DirectorGrant(A)200K——
Apr 1, 2024Pauza Charles DavidChief Science Officer VirologyGrant(A)98K——
Apr 1, 2024Pauza Charles DavidChief Science Officer VirologyGrant(A)503K——
Apr 1, 2024Pauza Charles DavidChief Science Officer VirologyGrant(A)333K——
Apr 1, 2024Redfield RobertActing Chief Medical OfficerGrant(A)98K——

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).